Shares of Marriott International, Inc. (NASDAQ:MAR) opened at $122.91, and ended -0.65% lower at $122.26. Nearly 3.04 million shares were traded by the close, higher than its average daily volume of 2.32 million shares.Marriott International, Inc. (MAR) Analyst Opinion
Marriott International, Inc. has a consensus outperform rating from 25 Wall Street analysts, and the number of shares currently sold short amount to at least 3.98% of shares outstanding. The stock spiked 6.28% last month and is up 47.87 this year. Wall Street is only getting more bullish on the stock, with 13 of analysts who cover MAR having a buy-equivalent rating. Analysts have placed a $117.75 price target on Marriott International, Inc., suggesting a -3.69% decline from recent close. It’s currently trading about -1.67% below its 52-week high.Marriott International, Inc. Earnings Surprise
Marriott International, Inc. (MAR) surprised the stock market in its last reported earnings when it earned $1.1 a piece versus the consensus-estimated $0.99. Its revenue totaled $5.23 billion down -9.77% from the previous quarter.Marriott International, Inc. (NASDAQ:MAR) Intraday View
This stock (MAR) is ahead of its 52-week low with 59.32%. Its last month’s stock price volatility remained 1.82% which for the week stands at 1.7%. The share price has moved forward from its 20 days moving average, trading at a distance of 2.88% and stays 8.28% away from its 50 days moving average. Over the last five days, shares have managed 1.9% gains and now is up 20.81% since hitting its 200-day moving average of $106.23. Marriott International, Inc. (MAR) has made its way to a 12-month gain of 57.33%.
Turning to Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), its shares were trading at $1.66 a gain of $0.04, on the trading floor. The stock, after opening at $1.7, touched a high of $1.79 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Imprimis Pharmaceuticals, Inc. tumbled -64.63% from its high of $4.69 to a $32.23 million market value through last close.Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Intraday Trading
The counter witnessed a trading volume of 0.53 million shares versus an average volume of 0.59 million shares during last trading session. Its last month’s stock price volatility remained 8.21% which for the week approaches 12.3%. The lowest price the stock reached in the last trading day was $1.65 and compares with the $1.35 52-week low. The stock recovered 22.89% since its low point and has performed -33.64% year-to-date.